Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Moorjani

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 15, 1989
Primary lipoprotein-lipase-activity deficiency: clinical investigation of a French Canadian populationC Gagné, L D Brun, P Julien, et al.
Clinical Pharmacology and Therapeutics|May 1, 1975
Dose-response to tibric acid: a new hypolipidemic drug in type IV hyperlipoproteinemiaP Bielmann, D Brun, S Moorjani, et al.
American Journal of Clinical Pathology|November 1, 1977
Effect of hyperchylomicronemia on the measurement of hemoglobinC Gagné, P L Auger, S Moorjani, et al.
The American Journal of Clinical Nutrition|March 1, 1996
Plasma lipoprotein profile and lipolytic activities in response to the substitution of lean white fish for other animal protein sources in premenopausal womenA Gascon, H Jacques, S Moorjani, et al.
The Canadian Journal of Cardiology|January 1, 1991
Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteinsP J Lupien, D Brun, C Gagné, et al.
Arteriosclerosis (Dallas, Tex.)|July 1, 1990
Regional distribution of body fat, plasma lipoproteins, and cardiovascular diseaseJ P Després, S Moorjani, P J Lupien, et al.
Molecular and Cellular Biochemistry|August 18, 1992
Genetic aspects of susceptibility to obesity and related dyslipidemiasJ P Després, S Moorjani, P J Lupien, et al.
International Journal of Clinical Pharmacology and Biopharmacy|April 1, 1977
Hypolipidemic effect of tibric acid. A comparison with clofibrate and placebo in type IV hyperlipoproteinemiaP Bielmann, D Brun, S Moorjani, et al.
Artery|January 1, 1982
Long term treatment of two familial hypercholesterolemic heterozygote patients with batch affinity chromatography (BAC)P J Lupien, S Moorjani, C Gagne, et al.
International Journal of Obesity|January 1, 1988
Effects of fenfluramine in hypertriglyceridemic obese subjectsL D Brun, P Bielmann, C Gagne, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 15, 1989
Primary lipoprotein-lipase-activity deficiency: clinical investigation of a French Canadian populationC Gagné, L D Brun, P Julien, et al.
Clinical Pharmacology and Therapeutics|May 1, 1975
Dose-response to tibric acid: a new hypolipidemic drug in type IV hyperlipoproteinemiaP Bielmann, D Brun, S Moorjani, et al.
American Journal of Clinical Pathology|November 1, 1977
Effect of hyperchylomicronemia on the measurement of hemoglobinC Gagné, P L Auger, S Moorjani, et al.
The American Journal of Clinical Nutrition|March 1, 1996
Plasma lipoprotein profile and lipolytic activities in response to the substitution of lean white fish for other animal protein sources in premenopausal womenA Gascon, H Jacques, S Moorjani, et al.
The Canadian Journal of Cardiology|January 1, 1991
Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteinsP J Lupien, D Brun, C Gagné, et al.
Arteriosclerosis (Dallas, Tex.)|July 1, 1990
Regional distribution of body fat, plasma lipoproteins, and cardiovascular diseaseJ P Després, S Moorjani, P J Lupien, et al.
Molecular and Cellular Biochemistry|August 18, 1992
Genetic aspects of susceptibility to obesity and related dyslipidemiasJ P Després, S Moorjani, P J Lupien, et al.
International Journal of Clinical Pharmacology and Biopharmacy|April 1, 1977
Hypolipidemic effect of tibric acid. A comparison with clofibrate and placebo in type IV hyperlipoproteinemiaP Bielmann, D Brun, S Moorjani, et al.
Artery|January 1, 1982
Long term treatment of two familial hypercholesterolemic heterozygote patients with batch affinity chromatography (BAC)P J Lupien, S Moorjani, C Gagne, et al.
International Journal of Obesity|January 1, 1988
Effects of fenfluramine in hypertriglyceridemic obese subjectsL D Brun, P Bielmann, C Gagne, et al.
Pageof 10